Pharmaceutical companies face growing threats from espionage and intercepted communications, putting intellectual property and sensitive data at risk. Despite investing in security measures, many overlook the vulnerabilities in mobile devices, messaging apps, and voice calls—particularly for executives and business travelers. This article explores the risks of unsecured communication channels, real-world threats to clinical trial data and proprietary research, and key strategies for strengthening security.
Check out the full Pharmaceutical Executive article here.
